- $336.23m
- $212.63m
- CNY5.47bn
- 58
- 99
- 69
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,230 | 1,300 | 1,780 | 3,271 | 5,467 |
Cost of Revenue | |||||
Gross Profit | 1,805 | 1,061 | 1,445 | 2,706 | 3,455 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,696 | 948 | 1,210 | 1,987 | 3,947 |
Operating Profit | 535 | 352 | 570 | 1,284 | 1,519 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 564 | 366 | 586 | 1,328 | 1,547 |
Provision for Income Taxes | |||||
Net Income After Taxes | 527 | 258 | 460 | 1,172 | 1,300 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 528 | 253 | 472 | 1,180 | 1,298 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 528 | 253 | 472 | 1,180 | 1,298 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.51 | 1.01 | 1.68 | 5.06 | 5.33 |